Stone H H, Fabian T C, Turkleson M L, Jurkiewicz M J
Ann Surg. 1981 May;193(5):612-8. doi: 10.1097/00000658-198105000-00011.
Over a 20-year interval, 167 patients sustained acute full-thickness abdominal wall loss due to necrotizing infection (124 patients), destructive trauma (32 patients), or en bloc tumor excision (11 patients). Polymicrobial infection or contamination was present in all but five of the patients. Of 13 patients managed by debridement and primary closure under tension, abdominal wall dehiscence occurred in each. Only two patients survived, the 11 deaths being caused by wound sepsis, evisceration, and/or bowel fistula. Debridement and gauze packing of a small defect was used in 15 patients; the single death resulted from recurrence of infectious gangrene. Pedicled flap closure, with or without a fascial prosthesis beneath, led to survival in nine of the 12 patients so-treated; yet flap necrosis from infection was a significant complication in seven patients who survived. The majority of patients (124) were managed by debridements, insertions of a fascial prostheses (prolene in 101 patients, marlex in 23 patients), and alternate day dressing changes, until the wound could be closed by skin grafts placed directly on granulations over the mesh or the bowel itself after the mesh had been removed. Sepsis and/or intestinal fistulas accounted for 25 of the 27 deaths. Major principles to evolve from this experience were: 1) insertion of a synthetic prosthesis to bridge any sizeable defect in abdominal wall rather than closure under tension or via a primarily mobilized flap; 2) use of end bowel stomas rather than exteriorized loops or primary anastomoses in the face of active infection, significant contamination, and/or massive contusion; and 3) delay in final reconstruction until all intestinal vents and fistulas have been closed by prior operation.
在20年的时间里,167例患者因坏死性感染(124例)、破坏性创伤(32例)或整块肿瘤切除(11例)导致急性全层腹壁缺损。除5例患者外,其余患者均存在多微生物感染或污染。在13例接受清创和张力下一期缝合治疗的患者中,每例均发生了腹壁裂开。仅2例患者存活,11例死亡原因是伤口脓毒症、肠管脱出和/或肠瘘。15例患者采用清创和小缺损纱布填塞治疗;1例死亡是由感染性坏疽复发所致。带蒂皮瓣修复,无论其下有无筋膜假体,12例接受该治疗的患者中有9例存活;然而,7例存活患者出现了因感染导致的皮瓣坏死这一严重并发症。大多数患者(124例)接受了清创、置入筋膜假体(101例使用普理灵,23例使用玛勒克斯)和隔日换药,直到伤口能够通过直接植皮于移除网片后的肉芽组织或肠管自身上而闭合。27例死亡患者中有25例是由脓毒症和/或肠瘘导致的。从这一经验中总结出的主要原则为:1)置入合成假体以填补腹壁任何较大缺损,而非张力下缝合或通过一期游离皮瓣修复;2)在存在活跃感染、严重污染和/或大面积挫伤时,使用肠造口而非外置肠袢或一期吻合;3)延迟最终重建,直至所有肠造口和肠瘘通过先前手术闭合。